
Knight Therapeutics
Specialty pharmaceutical company focused on acquiring or in-licensing.
Market cap
$474m
Enterprise value
$466m
Share price
CAD6.40 GUD.TO
Recent deals
Authorizing premium user...
Specialty pharmaceutical company focused on acquiring or in-licensing.